vs
Sol-Gel Technologies Ltd.（SLGL）与UNIVERSAL HEALTH REALTY INCOME TRUST（UHT）财务数据对比。点击上方公司名可切换其他公司
UNIVERSAL HEALTH REALTY INCOME TRUST的季度营收约是Sol-Gel Technologies Ltd.的1.4倍（$24.5M vs $17.3M），Sol-Gel Technologies Ltd.净利率更高（67.3% vs 17.7%，领先49.6%），Sol-Gel Technologies Ltd.同比增速更快（217.7% vs -0.7%）
Sol-Gel Technologies Ltd.是一家专注皮肤科药物研发的专业生物制药企业，依托专有溶胶凝胶递送技术开发痤疮、玫瑰痤疮、特应性皮炎等常见皮肤疾病的外用治疗方案，核心市场覆盖北美与欧洲，与医疗行业知名企业合作推进产品商业化。
环球健康服务公司（UHS）是一家总部位于宾夕法尼亚州普鲁士国王市的美国医疗服务企业，位列财富500强，主营医院运营及各类医疗保健服务。该公司2024年公布的总营收达158亿美元。
SLGL vs UHT — 直观对比
营收规模更大
UHT
是对方的1.4倍
$17.3M
营收增速更快
SLGL
高出218.4%
-0.7%
净利率更高
SLGL
高出49.6%
17.7%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $17.3M | $24.5M |
| 净利润 | $11.6M | $4.3M |
| 毛利率 | — | — |
| 营业利润率 | 65.1% | 34.7% |
| 净利率 | 67.3% | 17.7% |
| 营收同比 | 217.7% | -0.7% |
| 净利润同比 | 487.6% | -7.2% |
| 每股收益（稀释后） | $4.17 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SLGLUHT
| Q4 25 | — | $24.5M | ||
| Q3 25 | — | $25.3M | ||
| Q2 25 | $17.3M | $24.9M | ||
| Q1 25 | — | $24.5M | ||
| Q4 24 | — | $24.6M | ||
| Q3 24 | — | $24.5M | ||
| Q2 24 | $5.4M | $24.7M | ||
| Q1 24 | — | $25.1M |
净利润SLGLUHT
| Q4 25 | — | $4.3M | ||
| Q3 25 | — | $4.0M | ||
| Q2 25 | $11.6M | $4.5M | ||
| Q1 25 | — | $4.8M | ||
| Q4 24 | — | $4.7M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | $2.0M | $5.3M | ||
| Q1 24 | — | $5.3M |
营业利润率SLGLUHT
| Q4 25 | — | 34.7% | ||
| Q3 25 | — | 33.2% | ||
| Q2 25 | 65.1% | 35.6% | ||
| Q1 25 | — | 36.8% | ||
| Q4 24 | — | 37.6% | ||
| Q3 24 | — | 34.7% | ||
| Q2 24 | 29.9% | 38.7% | ||
| Q1 24 | — | 37.6% |
净利率SLGLUHT
| Q4 25 | — | 17.7% | ||
| Q3 25 | — | 15.9% | ||
| Q2 25 | 67.3% | 18.1% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | — | 18.9% | ||
| Q3 24 | — | 16.3% | ||
| Q2 24 | 36.4% | 21.3% | ||
| Q1 24 | — | 21.1% |
每股收益（稀释后）SLGLUHT
| Q4 25 | — | $0.32 | ||
| Q3 25 | — | $0.29 | ||
| Q2 25 | $4.17 | $0.32 | ||
| Q1 25 | — | $0.34 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | — | $0.29 | ||
| Q2 24 | $0.71 | $0.38 | ||
| Q1 24 | — | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.3M | $6.7M |
| 总债务越低越好 | — | $374.8M |
| 股东权益账面价值 | $31.9M | $152.4M |
| 总资产 | $39.3M | $564.9M |
| 负债/权益比越低杠杆越低 | — | 2.46× |
8季度趋势，按日历期对齐
现金及短期投资SLGLUHT
| Q4 25 | — | $6.7M | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | $24.3M | $6.6M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | — | $6.4M | ||
| Q2 24 | $26.5M | $5.6M | ||
| Q1 24 | — | $7.7M |
总债务SLGLUHT
| Q4 25 | — | $374.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $368.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益SLGLUHT
| Q4 25 | — | $152.4M | ||
| Q3 25 | — | $158.6M | ||
| Q2 25 | $31.9M | $165.2M | ||
| Q1 25 | — | $172.2M | ||
| Q4 24 | — | $179.5M | ||
| Q3 24 | — | $181.6M | ||
| Q2 24 | $34.9M | $190.7M | ||
| Q1 24 | — | $196.5M |
总资产SLGLUHT
| Q4 25 | — | $564.9M | ||
| Q3 25 | — | $568.0M | ||
| Q2 25 | $39.3M | $573.0M | ||
| Q1 25 | — | $573.5M | ||
| Q4 24 | — | $580.9M | ||
| Q3 24 | — | $584.3M | ||
| Q2 24 | $42.0M | $586.6M | ||
| Q1 24 | — | $596.2M |
负债/权益比SLGLUHT
| Q4 25 | — | 2.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $49.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 11.35× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流SLGLUHT
| Q4 25 | — | $49.1M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $13.7M | ||
| Q1 25 | — | $11.6M | ||
| Q4 24 | — | $46.9M | ||
| Q3 24 | — | $9.9M | ||
| Q2 24 | — | $12.1M | ||
| Q1 24 | — | $11.7M |
现金转化率SLGLUHT
| Q4 25 | — | 11.35× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 3.05× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 10.06× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 2.30× | ||
| Q1 24 | — | 2.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SLGL
暂无分部数据
UHT
| Reportable Segment Aggregation Before Other Operating Segment | $23.1M | 94% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $2.3M | 9% |
